Balyasny Asset Management’s AnaptysBio ANAB Stock Holding History

Balyasny Asset Management’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$272K	Buy	+4,905	New	+$264K	﹤0.01%	2599
2025 Q3	–	Sell	-92,852	Closed	-$2.06M	–	2882
2025 Q2	$2.06M	Buy	92,852 +60,778	+189%	+$1.27M	﹤0.01%	1712
2025 Q1	$596K	Buy	+32,074	New	+$535K	﹤0.01%	2211
2024 Q4	–	Sell	-303,211	Closed	-$10.2M	–	2693
2024 Q3	$10.2M	Buy	+303,211	New	+$10.4M	0.02%	946
2024 Q2	–	Sell	-15,746	Closed	-$355K	–	2540
2024 Q1	$355K	Sell	15,746 -3,202	-17%	-$75.8K	﹤0.01%	2196
2023 Q4	$406K	Buy	+18,948	New	+$327K	﹤0.01%	2031
2018 Q4	–	Sell	-88,957	Closed	-$8.88M	–	1370
2018 Q3	$8.88M	Buy	+88,957	New	+$7.38M	0.04%	530
2018 Q2	–	Sell	-151,319	Closed	-$15.7M	–	1761
2018 Q1	$15.7M	Buy	+151,319	New	+$17.1M	0.07%	391

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Balyasny Asset Management's ANAB Position: Q1 2026 in Review

Balyasny Asset Management opened a new position in AnaptysBio (ANAB) in Q1 2026: 4,905 shares worth $272K. The stake represents ﹤0.01% of the portfolio and ranks #2599 among its holdings. This is a return to the name: Balyasny Asset Management previously reported a position in ANAB as recently as Q2 2025.

Balyasny Asset Management first reported a position in ANAB in Q1 2018 and has held it in 8 quarters since. The position peaked at $15.7M in Q1 2018. 207 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.

Balyasny Asset Management held 4,905 shares of AnaptysBio worth $272K as of Q1 2026.
AnaptysBio was a new Balyasny Asset Management position in Q1 2026.
AnaptysBio made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #2599 holding.
Balyasny Asset Management first reported a position in AnaptysBio in Q1 2018 and has held it in 8 quarters since.
Balyasny Asset Management's AnaptysBio position peaked at $15.7M in Q1 2018.
207 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.